Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment

Autor: Protiere, Christel, Arnold, Michael, Fiorentino, Marion, Fressard, Lisa, Lelièvre, Jean D, Mimi, Mohamed, Raffi, François, Mora, Marion, Meyer, Laurence, Sagaon‐Teyssier, Luis, Zucman, David, Préau, Marie, Lambotte, Olivier, Spire, Bruno, Suzan‐Monti, Marie, Bergmann, J.F., Blacher, J., Blanc, A.P., Delobel, P., Girard, P.M., Goujard, C., Katlama, C., De Lacroix, I., Lafeuillade, A., Lelièvre, J.D., Lepeu, G., Michelet, C., Molina, J.M., Morlat, P., Peyramond, D., Piroth, L., Poizot‐Martin, I., Raffi, F., Ragnaud, J.M., Senneville, E., Weiss, L., Yazdanpanh, Y., Zucman, D.

Publikováno v: Journal of the International AIDS Society
Journal of the International AIDS Society, 2020, 23 (2), pp.e25443. ⟨10.1002/jia2.25443⟩
Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2020, 23 (2), pp.e25443. ⟨10.1002/jia2.25443⟩

International audience; INTRODUCTION:Despite the advent of HIV cure-related clinical trials (HCRCT) for people living with HIV (PLWH), the risks and uncertainty involved raise ethical issues. Although research has provided insights into the levers an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbca87b165ba3879999d6e938e6ffee
https://doi.org/10.1002/jia2.25443